The business and market models drugmakers must continually adapt to stay competitive as 2026 progresses.
Sarah Rickwood
Advertisement
Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. She has extremely wide experience of international pharmaceutical industry issues, consulting to the world’s leading pharmaceutical companies on global issues. She has been Vice President, European Thought Leadership at IQVIA for 13 years. Sarah presents to hundreds of pharmaceutical industry clients every year on a range of global pharmaceutical industry issues and publishes white papers on many topics including the uptake and impact of innovative medicines and challenges for Launch Excellence. Sarah holds a degree in biochemistry from Oxford University.
Articles by Sarah Rickwood
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
2
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
3
The Ongoing Impact of MFN Pricing
4
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
5